AVPN Global Conference 2023 | 20 - 22 June 2023

Days
Hrs
Mins
Secs

Tangtangquan (Online Patient Education Service)

We provide an app-based all-around care for people with type 1 diabetes that is currently the most widely used blood glucose management application in Chinese mainland.

By

Shenzhen Aibaowei Biotechnology CO., LTD.

Click here to learn more about the Impact Organisation

This is member exclusive
content. Click here to unlock

Social causes

Beneficiaries

SDGs covered

Market of Implementation

  • China

Problem

Type 1 diabetes is a lifelong disease and can not be cured for now. Low patient compliance and low glucose management efficiency are the problems encountered.

Solution

More than 60 percent of our users are from undeveloped areas in China, and it indicates that through mobile internet method, the people in poverty areas can also receive good medical resources.

We develop a "peer support" system and a doctor follow-up system that let the people in remote areas get help from the patient leader and doctor for free when needed.

Unlock this content

This is member exclusive content. Become an AVPN member and unlock more insightful content.

Deal Share - Contact

Hidden

Deal Share - Contact

Hidden